Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

HIV Postexposure Prophylaxis With Darunavir/r (PEPDar)

NCT01516970 is registered in ClinicalTrials.gov with Janssen-Cilag G.m.b.H as lead sponsor.

NCT NCT01516970
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01516970 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
HIV Postexposure Prophylaxis With Darunavir/r (PEPDar)
Lead sponsor
Janssen-Cilag G.m.b.H
Phase
Phase 3
Overall status
Completed
Start date
November 25, 2011
Completion date
September 28, 2013
Enrollment
312 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

human immunodeficiency virus (hiv)